Tailored Health Literacy Follow-up in Cancer

March 30, 2023 updated by: Christine Råheim Borge, Lovisenberg Diakonale Hospital

Tailored Health Literacy Follow-up in Cancer - the Tail HealthLit Cancer Trial

Health literacy refers to personal and relational factors affecting a persons ability to aquire, understand and use health information and health services. In a need assessment study, it was found that there is a need to focus on health literacy factors in the follow-up of people with cancer in the health care services.

Thus, this project evaluate the effect of a health literacy intervention in cancer. The intervention provides patients with nurse-led tailored follow-up by phone/digital/personal meetings that addresses their individual HL needs, particularly those needs that impact their quality of life, symptom burden, self-management, and health economic costs. Our main goal is to improve the patients' health literacy, with secondary goals of improving their quality of life, symptom burden, and self-management, and reducing their health care costs.

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Anticipated)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Christine R Borge, PhD
  • Phone Number: +47 23225000
  • Email: chrr@lds.no

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosed with cancer
  • Above 18 years old
  • Receiving treatment at the main intervention hospital

Exclusion Criteria:

  • Not diagnosed with cancer
  • Not above 18 years old
  • Not in treatment at the intervention hospital

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: The Intervention Group
The intervention group will receive a tailored intervention based on each individuals health literacy needs. A project nurse with broad experience in cancer care will be trained in Motivational Interviewing techniques to provide follow-up for the patients in the intervention group in a period of 9 months.
  1. Participants are invited to a consultation with the project nurse where the project nurse will use baseline data to identify the patient's HL needs, QOL, symptom burden and issues related to self-management of their cancer and treatment. These data will be used together with an interview questionnaire specifically developed to communicate HL needs (i.e. CHAT), which form the basis for the individualized HL support.
  2. Actions: Based on results of the consultation, the project nurse and the patient will use a worksheet of possible actions to identify those most relevant to the patient's individual needs. Based on this, different self-management tasks and actions will be offered, and an individual tailored follow-up plan will be made. The patient and the project nurse will use a workbook containing information on the follow-up plan that will be added into medical record.
  3. Telephone/digital conversations with the project every second month for a period of 9 months.
No Intervention: Usual care group
Usual care group will receive usual follow-up.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
General Health literacy measured with the Health Literacy Questionnaire (HLQ)
Time Frame: 6 months, 9 months
Change of Health Literacy questionnaire
6 months, 9 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Electronic Health Literacy measured with the electronic Health Literacy Questionnaire (eHLQ)
Time Frame: 6 months, 9 months
Change of electronic Health Literacy questionnaire
6 months, 9 months
General symptoms measured with the Edmonton Symptom Assessment System (ESAS)
Time Frame: 6 months, 9 months
Change of symptom burden questionnaire
6 months, 9 months
Oral symptoms measured with four items selected from the European Organization for REsearch and Treatment of Cancer-oral health 15 (EORTC-OH 15)
Time Frame: 6 months, 9 months
Change in oral symptoms
6 months, 9 months
Self-management measured with the Health Education Impact Questionnaire (HeiQ)
Time Frame: 6 months, 9 months
Change of self-management questionnaire
6 months, 9 months
Self-Efficacy measured with the General Self-efficacy Scale (GSE)
Time Frame: 6 months, 9 months
Change of Self-efficacy questionnaire
6 months, 9 months
Disease specific Quality of Life measured with the The functional Assessment of Cancer Therapy-General (FACT-G)
Time Frame: 6 months, 9 months
Change of quality of life questionnaire
6 months, 9 months
Generic health-related quality of life/quality adjusted life years measured by the EQ-5D
Time Frame: 6 months, 9 months
Change in health related quality of life and adjusted life years
6 months, 9 months
Health care costs measured through collecting data from patient medical records, patient self-report, and data registers
Time Frame: 6 months, 9 months
Change of health care costs
6 months, 9 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Christine R Borge, PhD, Lovisenberg Diaconal Hospital and University of Oslo
  • Study Chair: Astrid K Wahl, PhD, University of Oslo
  • Study Chair: Simen A Steindal, PhD, VID

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 30, 2023

Primary Completion (Anticipated)

December 31, 2024

Study Completion (Anticipated)

December 31, 2026

Study Registration Dates

First Submitted

November 10, 2022

First Submitted That Met QC Criteria

November 23, 2022

First Posted (Actual)

November 25, 2022

Study Record Updates

Last Update Posted (Actual)

April 3, 2023

Last Update Submitted That Met QC Criteria

March 30, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 341

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Clinical Trials on Tailored Health Literacy follow-up in cancer

3
Subscribe